Company intelligence / Profile preview

Deurali-Janta Pharmaceuticals

Kathmandu, Bagmati, Nepal

Ownership: Private
Development stage: Other

Overview

Deurali-Janta Pharmaceuticals is Nepal’s largest pharmaceutical manufacturer, with WHO-GMP and ISO certifications, offering over 250 commercial products across cardiovascular, endocrinology, neuropsychiatry, nephrology, dermatology, gastrology, women & child health, and general medicine segments, and is focused on expanding to international markets[1][3][8].

Therapeutic areas: CardiovascularImmunologyEndocrinologyRheumatologyGastroenterologyInfectious DiseasesPulmonologyWomen's HealthHematologyDermatologyPsychiatry
Modalities: Small moleculeBiologicProteinVaccineAntibiotic (as product class)
Industry: Biotech

Partnerships

RENATA (technology transfer partner, Bangladesh)

Beyond the preview

Go deeper on Deurali-Janta Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deurali-Janta Pharmaceuticals.

Explore the full profile